Salvatore Mirto
Salvatore Mirto publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Lymphocytic Leukemia Research.
- World rank
- #5,706,530 of 7,710,434 ranked researchers
- Rank in Italy
- #190,396 of 242,206
- Works
- 49
- Citations
- 869
- Citations per work
- 17.7
What does Salvatore Mirto research?
Salvatore Mirto's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3979.2%
- Medicine3979.2%
- Everything else612.2%
- Life Sciences48.6%
- 1Hematology41% of their works
- 2Genetics16% of their works
- 3Public Health, Environmental and Occupational Health12% of their works
- 4Molecular Biology9% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Oncology4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Retinoids in leukemia and cellular processes
Which keywords describe Salvatore Mirto's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer and Chronic Lymphocytic Leukemia.
- Acute Promyelocytic Leukemia
- JAK2 Mutation
- Graft-versus-Host Disease
- Bone Marrow Niche
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Rituximab
- Childhood Cancer
- Genomic Aberrations
- Imatinib
- Classification
- Lymphoma
- Myelofibrosis
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors643 topics
- Hematopoietic Stem Cells402 topics
- AML321 topic
- Acute Myeloid Leukemia321 topic
- Rituximab232 topics
- Acute Lymphoblastic Leukemia171 topic
- Childhood Cancer171 topic
- Chronic Lymphocytic Leukemia151 topic
- Genomic Aberrations151 topic
- BCR-ABL141 topic
- Imatinib141 topic
- Bone Marrow Niche81 topic
- Classification81 topic
- Graft-versus-Host Disease81 topic
- Lymphoma81 topic
- JAK2 Mutation71 topic
- Myelofibrosis71 topic
- Acute Promyelocytic Leukemia31 topic
- Retinoic Acid31 topic
Where does Salvatore Mirto work?
Salvatore Mirto's main affiliation in the publication record is Ospedale Vincenzo Cervello, Italy.
How many publications and citations does Salvatore Mirto have?
OpenAlex counts 49 works and 869 citations for Salvatore Mirto, an h-index of 17, ranking #5,706,530 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Salvatore Mirto. Posts are plain text and can be reported.